Insider Buying: RXO (NYSE:RXO) Director Buys $88,243.37 in Stock

Rxo Inc (NYSE:RXO) Director Troy Cooper acquired 8,317 shares of the firm’s stock in a transaction that occurred on Thursday, November 20th. The shares were purchased at an average price of $10.61 per share, with a total value of $88,243.37. Following the acquisition, the director owned 275,416 shares of the company’s stock, valued at approximately $2,922,163.76. This trade represents a 3.11% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

RXO Trading Up 0.1%

RXO opened at $13.01 on Thursday. The firm’s fifty day moving average is $15.36 and its two-hundred day moving average is $15.83. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.32 and a current ratio of 1.32. The firm has a market cap of $2.14 billion, a PE ratio of -30.26 and a beta of 1.67. Rxo Inc has a twelve month low of $10.43 and a twelve month high of $31.11.

RXO (NYSE:RXO) last announced its quarterly earnings results on Thursday, November 6th. The company reported $0.01 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.03 by ($0.02). RXO had a negative net margin of 1.25% and a positive return on equity of 0.88%. The firm had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.44 billion. During the same period last year, the firm earned $0.05 EPS. RXO’s quarterly revenue was up 34.6% on a year-over-year basis. Equities research analysts anticipate that Rxo Inc will post 0.31 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the company. Stifel Nicolaus raised their price target on RXO from $14.00 to $17.00 and gave the stock a “hold” rating in a research report on Friday, October 10th. Morgan Stanley raised RXO from an “equal weight” rating to an “overweight” rating and set a $19.00 target price for the company in a research note on Tuesday, November 11th. Wall Street Zen lowered shares of RXO from a “hold” rating to a “sell” rating in a research note on Saturday, November 8th. Cowen reiterated a “hold” rating on shares of RXO in a report on Friday, August 8th. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of RXO in a report on Monday. Four research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and four have issued a Sell rating to the company’s stock. Based on data from MarketBeat, RXO has an average rating of “Hold” and a consensus price target of $16.69.

Hedge Funds Weigh In On RXO

A number of large investors have recently bought and sold shares of RXO. AlphaQuest LLC acquired a new stake in shares of RXO in the second quarter valued at approximately $29,000. Geneos Wealth Management Inc. bought a new position in RXO in the first quarter valued at $30,000. Quarry LP acquired a new stake in RXO in the 3rd quarter valued at $33,000. CWM LLC lifted its position in RXO by 234.4% during the 1st quarter. CWM LLC now owns 1,876 shares of the company’s stock worth $36,000 after buying an additional 1,315 shares in the last quarter. Finally, Larson Financial Group LLC boosted its stake in shares of RXO by 146.5% during the 3rd quarter. Larson Financial Group LLC now owns 2,766 shares of the company’s stock worth $43,000 after buying an additional 1,644 shares during the last quarter. Institutional investors and hedge funds own 92.73% of the company’s stock.

RXO Company Profile

RXO, Inc provides full truckload freight transportation brokering services. It also offers brokered services for managed transportation, last mile, and freight forwarding. The company was incorporated in 2022 and is based in Charlotte, North Carolina.